Malignant Connective Tissue Tumours of the Oral and Maxillofacial Region
The Diagnostic Table – SLIDE 360
Malignant connective tissue tumours can present particular diagnostic challenges when encountered in the oral and maxillofacial region.
Join Prof. Dr Aadithya B. Urs, Senior Professor and Head, Department of Oral Pathology, Maulana Azad Institute of Dental Sciences, New Delhi, for an interactive, case-based exploration of these challenging lesions.
What makes this session different?
Rather than simply watching a lecture, you’ll have the opportunity to examine selected case images independently before the live session.
Consider the morphological features, develop your differential diagnoses and then join the expert-led discussion to explore the diagnostic reasoning and systematic approach to each case.
Your enrolment includes
- Pre-session self-study: Selected case images for independent review.
- Live expert discussion: A step-by-step approach to challenging diagnoses.
- Recording access: Revisit the discussion after the live session.
- Certificate of completion: Available after fulfilling the course requirements within the specified deadline.
*A non-accredited certificate of completion is provided upon fulfilling the course requirements. Participants may be able to claim learning hours towards CPD/CDE requirements, subject to the rules of their professional body or jurisdiction.
Session details
Date: Saturday, 12 December 2026
Time: 17:30–19:00 IST
Faculty: Prof. Dr Aadithya B. Urs
Format: Online, interactive case-based session
Who should attend?
Especially relevant for oral pathology postgraduate students, recent graduates, practising oral pathologists and specialists interested in challenging oral and maxillofacial diagnoses.
How to participate
After purchasing the course, access it through your Oromed 360 Academy account.
The course will provide the preparatory case images when available, along with instructions to receive your personalised Zoom joining link.
Early-booking price available until 5 December 2026.
